74572-19-3

Basic information

• Product Name: trans-octahydro-2H-1,4-benzoxazine(SALTDATA: HBr)
• Synonyms: trans-octahydro-2H-1,4-benzoxazine(SALTDATA: HBr);Octahydro-2H-1,4-benzoxazine hydrobromide;octahydro-2H-benzo[b][1,4]oxazine hydrobromide;trans-octahydro-2H-1,4-benzoxazine
• CAS NO: 74572-19-3
• Molecular Formula: C8H16BrNO
• Molecular Weight: 222.12274
• Mol File: 74572-19-3.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: trans-octahydro-2H-1,4-benzoxazine(SALTDATA: HBr)(CAS DataBase Reference)
• NIST Chemistry Reference: trans-octahydro-2H-1,4-benzoxazine(SALTDATA: HBr)(74572-19-3)
• EPA Substance Registry System: trans-octahydro-2H-1,4-benzoxazine(SALTDATA: HBr)(74572-19-3)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 74572-19-3(Hazardous Substances Data)

Usage

Description

Trans-octahydro-2H-1,4-benzoxazine(SALTDATA: HBr) is a chemical compound that features a heterocyclic ring and a bromide ion. It is widely recognized for its role in organic synthesis and as a precursor in the production of pharmaceuticals, agrochemicals, and functional materials.
Used in Organic Synthesis:
Trans-octahydro-2H-1,4-benzoxazine(SALTDATA: HBr) is used as a key intermediate in organic synthesis for the creation of various complex organic molecules. Its unique structure allows for versatile reactions, making it a valuable component in the synthesis of a broad range of compounds.
Used in Pharmaceutical Production:
In the pharmaceutical industry, trans-octahydro-2H-1,4-benzoxazine(SALTDATA: HBr) is utilized as a precursor for the development of new drugs. Its ability to form heterocyclic rings and its reactivity with other molecules make it an essential building block in medicinal chemistry.
Used in Agrochemical Development:
Trans-octahydro-2H-1,4-benzoxazine(SALTDATA: HBr) is also employed in the agrochemical sector, where it serves as a starting material for the synthesis of pesticides and other agricultural chemicals. Its properties contribute to the development of effective and targeted agrochemicals.
Used in Functional Materials:
trans-octahydro-2H-1,4-benzoxazine(SALTDATA: HBr) is used as a component in the preparation of functional materials, which have specific properties and applications in various industries. Its role in creating these materials is crucial for advancing technology and improving product performance.
Safety Precautions:
It is important to handle and store trans-octahydro-2H-1,4-benzoxazine(SALTDATA: HBr) with care, as it may pose health hazards if not properly managed. Adhering to proper safety protocols is essential to prevent any potential harm to individuals or the environment.

Upstream product

• 95628-91-4 rac-trans-N-(2'-Hydroxycyclohexyl)-2-chloroacetamide 
• 126936-85-4 rac-trans-Octahydro-2H-1,4-benzoxazin-3-one 
• 931-16-8 (+/-)-trans-2-aminocyclohexanol 
• 142034-77-3 (trans-4a,8a)-hexahydro-2H-1,4-benzoxazin-3(4H)-one 
• 931-15-7 (1R,2R)-2-aminocyclohexanol 
• 142034-76-2 2-chloro-N-[trans-(1,2)-2-hydroxycyclohexyl]acetamide 
• 74572-18-2 Toluene-4-sulfonic acid 2-[(2-hydroxy-cyclohexyl)-(toluene-4-sulfonyl)-amino]-ethyl ester 
• 286-20-4 cyclohexane-1,2-epoxide 
• 85515-95-3 trans-RS-N-(β-hydroxyethyl)-2-amino-1-cyclohexanol 
• 74572-17-1 trans-RS-N-p-toluensulphonyl-octahydro-1,4-benzoxazine 
• 5735-53-5 1,4-benzoxazine 
• 5466-88-6 3,4-dihydro-3-oxo-2H-1,4-benzoxazine 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS MTOR INHIBITORS

The present disclosure describes novel heterocyclic mTOR inhibitors and methods for preparing them. The pharmaceutical compositions comprising such mTOR inhibitors and methods of using them for treating cancer, infectious diseases, and other mTOR associated disorders are also described.

A concise and efficient synthesis of substituted morpholines

A simple and efficient method has been developed for the synthesis of substituted morpholines by a sequence of coupling, cyclization, and reduction reactions of easily available amino alcohols and α-halo acid chlorides. Various mono-, di-, and trisubstituted morpholines, spiro morpholines, and ring-fused morpholines, as well as morpholine homologues, were synthesized in good to excellent yields by a single methodology under similar reaction conditions. The method was also used in a multigram synthesis of (3S)-3-methylmorpholine.

AMIDO-THIOPHENE COMPOUNDS AND THEIR USE

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain amido-thiophene compounds that, inter alia, inhibit 11 β-hydroxysteroid dehydrogenase type 1 (11 β-HSD1 ). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 11 β-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11 β-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.